ROCK of Africa Foundation is providing food, clothing, medicine and medical supplies to poverty stricken regions of Africa. The foundation also promotes research and development of solutions to medical problems facing poor in underdeveloped countries in Africa and throughout the world.
Medicine for Africa Research
Under the direction of Carl P. Schaffner, Ph.D., professor
emeritus at the Waksman Institute of Rutgers University, ROCK of Africa
Foundation is assisting in development of new medicine to treat victims of
HIV/AIDS in Africa.
The vast majority of people infected with the HIV virus in sub-Saharan Africa receive no medicine at all to treat the virus. The obvious reason is cost. Teams of researchers in the US and Africa are donating their time to develop low cost medicines for treating disease in the Third World.
ROCK of Africa Foundation has established collaborative research relationships with researchers in the United States, South Africa and Ghana, West Africa.
AME -- Amphotericin B Methyl Ester
A patent free medication to treat HIV/AIDS victims in the Third World. AME is a derivative of Amphotericin B, a highly effective medication for treatment of fungal disease.
Benefits of AME:
-
Low cost medication treatment for HIV/AIDS patients in the Third World
Medication free of patents, can legally be manufactured by any company. Competitive manufacture is the key to lower cost. -
Dual efficacy
In addition to fighting the HIV virus, AME is highly effective in fighting fungal disease which claims the lives of many AIDS patients. -
Outpatient treatment from Rural Clinics
